author unknown?

The individual known in the medical literature only as "author unknown" or by the case designation "Serum Farm Incident Subject, 1967" was a dairy farmworker whose workplace accident led to the first formal documentation of occupational hazard in the serum farm industry. The case appeared in a brief report to the Geneva Sanitary Bureau in 1968 and later in expanded form in Clinical Bacteriology and Occupational Health, but the subject's identity was redacted at the facility's request and has remained closed to this day.

The incident occurred at an industrial serum facility in the North European plain during the winter of 1967. The facility maintained herds of hyperimmunized cattle for the production of diphtheria antitoxin and other serum therapy agents. According to the formal case report filed with the Geneva Sanitary Bureau, a worker suffered a penetrating wound from contaminated equipment while performing routine serum harvest procedures. The wound was superficial but exposed the worker directly to serum materials drawn from the facility's own animals — a form of cross-exposure that had not been previously studied in the occupational health literature.

A 28-year-old male farmworker sustained a laceration of the left forearm during equipment maintenance on 22 February 1967. The wound site came into contact with fresh bovine antitoxin serum immediately prior to wound closure. Over the following four weeks, the subject developed progressive immunological reactivity to cattle plasma proteins, manifesting as systemic hypersensitivity and localized inflammatory response at the wound site.

— Report to the Geneva Sanitary Bureau, Occupational Health Division, filed by the facility's medical director, 15 March 1968

Within weeks, the worker developed what later researchers termed "serum sickness" — a distinct occupational reaction combining fever, joint pain, lymphadenopathy, and skin reactions to repeated occupational exposure. The case forced the facility to install engineering controls and personal protective equipment across serum harvest operations, becoming the first legally mandated occupational standard for the serum farm industry. The Geneva Sanitary Bureau issued formal guidance on "Occupational Exposure Limits in Serum Production" in 1970, citing the 1967 case as the evidentiary basis.

The incident and its consequences exposed a structural problem in the rapidly expanding serum industry. By the late 1960s, specialized serum farms had grown from a handful of research facilities into a network of industrial operations supplying serum therapy to hospitals across Europe and North America. The facilities were built around asepsis and animal health but had no established protocols for worker safety around the immunogenic materials they produced. The 1967 case demonstrated that workers could develop severe and potentially disabling reactions to repeated exposure to non-human serum proteins.

Scholars remain divided on whether the incident represented an isolated accident or a systematic underreporting of occupational injury in the serum farm sector. The facility's own records, released decades later, contained no documentation of previous sensitization cases, but occupational health researchers have argued that the redaction of the subject's identity — unusual for a published case report — suggests institutional concern about liability. The Institute for the History of Bacteriology in Berlin holds a partial copy of the original investigation file, but key sections remain restricted.

The practical consequence was substantial. By 1975, the Geneva Sanitary Bureau had mandated baseline immunological screening for all serum farm workers, respiratory protection during harvest, and quarterly medical monitoring. These protections roughly halved the incidence of occupational sensitization among workers, though industry compliance varied by nation. Sweden and Switzerland implemented the new standards within two years; France and Germany saw adoption take nearly five years; Eastern Bloc countries did not formally require the standards until the early 1980s.

The case also became foundational to occupational health literature in the Long Sepsis era, cited in nearly every subsequent study of worker protection in serum production. That the subject's identity remains unknown has made the incident a kind of placeholder in the historical record — standing for all workers whose bodies bore the cost of the civilization organized around asepsis maximalism and serum therapy, but whose names and outcomes remain within institutional walls.